CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase-Reference-Cited by-同舟云学术

CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase

Published:2018-09-12 Issue:2 Volume:33 Page:518-558
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hernández-Sánchez María,Kotaskova Jana,Rodríguez Ana E,Radova Lenka,Tamborero David,Abáigar María,Plevova Karla,Benito Rocío,Tom Nikola,Quijada-Álamo Miguel,Bikos Vasileos,Martín Ana África,Pal Karol,García de Coca Alfonso,Doubek Michael,López-Bigas Nuria,Hernández-Rivas Jesús-María,Pospisilova Sarka

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0255-1.pdf

Reference15 articles.

1. Landau DA, Wu CJ. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics. Genome Med. 2013;5:47.

2. Puente XS, Bea S, Valdes-Mas R, Villamor N, Gutierrez-Abril J, Martin-Subero JI, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526:519–24.

3. Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525–30.

4. Ljungstrom V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood. 2016;127:1007–16.

5. Burger JA, Landau DA, Taylor-Weiner A, Bozic I, Zhang H, Sarosiek K, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment‐naïve CLL patients;British Journal of Haematology;2023-12-07

2. Transcription factor abnormalities in B-ALL leukemogenesis and treatment;Trends in Cancer;2023-10

3. The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion;Hematological Oncology;2023-07-03

4. CRISPR/Cas9 in Chronic Lymphocytic Leukemia;Encyclopedia;2022-05-07

5. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes;BMC Cancer;2022-02-03